Investigation into Ebola Outbreak Origins Focuses on Pastor's Funeral as Possible Super-Spreader Event
Investigators hunting for the source of a Bundibugyo Ebola outbreak in the Democratic Republic of Congo are examining the February 4 funeral of a 44-year-old pastor whose coffin cracked during transport, potentially exposing mourners to the virus. The pastor was never tested for Ebola but died of peritonitis, a condition that can manifest in severe Ebola infections, and the funeral preceded dozens of deaths in the area. Understanding the outbreak's origin is critical for containing the epidemic, which has caused at least 635 confirmed infections and 127 deaths, with health officials warning the true toll may be much higher.
Health investigators examining the Bundibugyo Ebola outbreak in eastern Democratic Republic of Congo are scrutinizing the February 4 funeral of Pastor Paluku Makundi Denis as a potential super-spreader event. The pastor's coffin cracked during a three-hour transport from Bunia to Mongbwalu after relatives sat on it, and the body was transferred to a new casket by residents who touched the remains before community members gathered for the funeral—a high-risk scenario if Makundi had Ebola, as deceased victims' bodies are highly infectious. Makundi died of peritonitis, diagnosed at a Bunia hospital on February 3, but was never tested for Ebola because Congolese officials were unaware of any outbreak at the time. An infectious-disease expert noted that peritonitis can be a manifestation of severe Ebola, though confirmation would require testing. A surveillance epidemiologist on the inquiry estimated the Bundibugyo strain had been circulating for four to six months before the official outbreak confirmation on May 15. The outbreak has caused approximately 635 confirmed infections and at least 127 deaths, with the true toll potentially much higher.
What different sources said
- ReutersCenter
A cracked coffin, a funeral and the hunt for Ebola's patient zero
- The Straits TimesCenter
A cracked coffin, a funeral and the hunt for Ebola's patient zero
Related
Study Shows Experimental Drug Could Preserve Muscle Mass in GLP-1 Weight-Loss Users
A clinical trial published in Nature Medicine found that combining the weight-loss drug tirzepatide with an experimental antibody called apitegromab helped patients retain approximately 55% more muscle mass compared to tirzepatide alone. GLP-1 medications, now used by roughly one in eight US adults, typically result in 25-40% of weight loss coming from lean body mass rather than fat. The findings could address a side effect known as "Ozempic butt" and have implications for treating age-related muscle loss and other conditions.
Motorcycle Campaign Spreads Ebola Prevention Messages in Eastern DR Congo
Dozens of motorcycle taxi drivers in eastern Democratic Republic of Congo participated in an awareness campaign carrying Ebola prevention messages and countering misinformation about the outbreak. The campaign, organized with WHO support, took place in Bunia and Rwampara in Ituri province, the region most affected by the current outbreak. The effort reflects ongoing challenges in combating disease skepticism and building public trust during health emergencies.
FDA Grants Emergency Approval for Over-the-Counter Screwworm Treatment for Pets
The FDA has granted emergency use authorization for nitenpyram, an over-the-counter tablet, to treat New World screwworm infections in dogs and cats. This marks the first generic animal drug approved for screwworm treatment as cases have emerged in Texas, New Mexico, and other states after a decade without US cases. The approval provides pet owners with a rapid treatment option as screwworm, a parasitic infection spread by flies, resurfaces in the country.